Christine Ring Nurix Therapeutics, Inc. (NRIX) insider trading activity

NRIX Quotes by TradingView

Christine Ring is Chief Legal Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 28,084 shares of NRIX, which is worth approximately $635,821. The most recent transaction as insider was on Jun 05, 2024, when has been sold 400 shares (Common Stock) at a price of $1.86 per share, resulting in proceeds of $744. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.1K
14.2% 3M change
84.0% 12M change
Total Value Held $635,821

Christine Ring Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Exercise of conversion of derivative security
$744 $1.86 p/Share
400 Added 1.94%
20,238 Common Stock
Jun 03 2024
SELL
Open market or private sale
$27,147 $17.01 p/Share
1,596 Reduced 7.45%
19,838 Common Stock
Jun 03 2024
BUY
Exercise of conversion of derivative security
$2,968 $1.86 p/Share
1,596 Added 6.93%
21,434 Common Stock
Apr 30 2024
SELL
Open market or private sale
$18,216 $12.04 p/Share
1,513 Reduced 7.09%
19,838 Common Stock
Apr 30 2024
BUY
Exercise of conversion of derivative security
-
3,924 Added 15.53%
21,351 Common Stock
Jan 30 2024
SELL
Open market or private sale
$14,062 $7.99 p/Share
1,760 Reduced 9.17%
17,427 Common Stock
Jan 30 2024
BUY
Exercise of conversion of derivative security
-
3,924 Added 16.98%
19,187 Common Stock
Oct 31 2023
SELL
Open market or private sale
$6,406 $5.2 p/Share
1,232 Reduced 7.47%
15,263 Common Stock
Oct 30 2023
BUY
Exercise of conversion of derivative security
-
3,924 Added 19.22%
16,495 Common Stock
Jul 31 2023
SELL
Open market or private sale
$13,703 $9.65 p/Share
1,420 Reduced 10.17%
12,544 Common Stock
Jul 30 2023
BUY
Exercise of conversion of derivative security
-
3,924 Added 21.94%
13,964 Common Stock
May 01 2023
SELL
Open market or private sale
$6,738 $9.88 p/Share
682 Reduced 6.36%
10,040 Common Stock
Apr 30 2023
BUY
Exercise of conversion of derivative security
-
1,924 Added 15.21%
10,722 Common Stock
Jan 30 2023
SELL
Open market or private sale
$9,989 $11.78 p/Share
848 Reduced 10.46%
7,261 Common Stock
Jan 30 2023
BUY
Exercise of conversion of derivative security
-
1,924 Added 19.18%
8,109 Common Stock
Oct 31 2022
SELL
Open market or private sale
$9,003 $12.88 p/Share
699 Reduced 10.15%
6,185 Common Stock
Oct 30 2022
BUY
Exercise of conversion of derivative security
-
1,924 Added 21.84%
6,884 Common Stock
Aug 01 2022
SELL
Open market or private sale
$11,157 $15.67 p/Share
712 Reduced 13.37%
4,615 Common Stock
Jul 30 2022
BUY
Exercise of conversion of derivative security
-
1,924 Added 26.53%
5,327 Common Stock
May 02 2022
SELL
Open market or private sale
$7,755 $11.75 p/Share
660 Reduced 16.24%
3,403 Common Stock
Apr 30 2022
BUY
Exercise of conversion of derivative security
-
1,924 Added 32.14%
4,063 Common Stock
Jan 10 2022
SELL
Open market or private sale
$32,568 $27.14 p/Share
1,200 Reduced 48.27%
1,286 Common Stock
Jan 10 2022
BUY
Exercise of conversion of derivative security
$2,232 $1.86 p/Share
1,200 Added 32.56%
2,486 Common Stock
Dec 10 2021
SELL
Open market or private sale
$34,848 $29.04 p/Share
1,200 Reduced 48.27%
1,286 Common Stock
Dec 10 2021
BUY
Exercise of conversion of derivative security
$2,232 $1.86 p/Share
1,200 Added 32.56%
2,486 Common Stock
CR

Christine Ring

Chief Legal Officer
San Francisco, CA

Track Institutional and Insider Activities on NRIX

Follow Nurix Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

News

Receive news related to Nurix Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRIX